TP53 and non-small cell lung carcinoma: Therefore, the mechanisms by which the combination inhibits NSCLC can be classified into two signaling pathways depending on the genetic status of p53: DNA replication stress-dependent or independent apoptotic cell death pathways (Fig. 6).